Effect on sexual function of long-term treatment with selective serotonin reuptake inhibitors in depressed patients treated in primary care / Lisa Ekselius en Journal of Clinical Psychopharmacology, Año 2001 - Vol. 21 - No. 2 (Abril)

Público ISBD [artículo]  inJournal of Clinical Psychopharmacology > Año 2001 - Vol. 21 - No. 2 (Abril) . - pp. 154-160 Título : Effect on sexual function of long-term treatment with selective serotonin reuptake inhibitors in depressed patients treated in primary care Tipo de documento: texto impreso Autores: Lisa Ekselius, Autor ; Lars von Knorring, Autor Fecha de publicación: 2023 Artículo en la página: pp. 154-160 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Trastorno depresivo mayor, Primeros auxilios, Inhibidores selectivos de la recaptación de serotonina, Sertralina, Disfunciones Sexuales. Resumen: The purpose of this study was to prospectively examine the occurrence and severity of sexual dysfunction symptoms in depressed patients before and after 6 months of treatment with selective serotonin reuptake inhibitors. The study was part of a randomized, double-blind, controlled trial of sertraline or citalopram in patients with a DSM-III-R major depressive disorder treated by general practitioners. Link: ./index.php?lvl=notice_display&id=31119 [artículo] Effect on sexual function of long-term treatment with selective serotonin reuptake inhibitors in depressed patients treated in primary care [texto impreso] / Lisa Ekselius, Autor ; Lars von Knorring, Autor . - 2023 . - pp. 154-160. Idioma : Inglés (eng) Idioma original : Inglés (eng) in Journal of Clinical Psychopharmacology > Año 2001 - Vol. 21 - No. 2 (Abril) . - pp. 154-160 Palabras clave: Trastorno depresivo mayor, Primeros auxilios, Inhibidores selectivos de la recaptación de serotonina, Sertralina, Disfunciones Sexuales. Resumen: The purpose of this study was to prospectively examine the occurrence and severity of sexual dysfunction symptoms in depressed patients before and after 6 months of treatment with selective serotonin reuptake inhibitors. The study was part of a randomized, double-blind, controlled trial of sertraline or citalopram in patients with a DSM-III-R major depressive disorder treated by general practitioners. Link: ./index.php?lvl=notice_display&id=31119

---

1 (1 - 1 / 1)